Feedback (FDBK) Competitors

GBX 82.50
0.00 (0.00%)
(As of 05/3/2024 ET)

FDBK vs. INHC, COG, IQAI, TRLS, RENX, TLY, CHLL, BVX, BELL, and MXC

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), Cambridge Cognition (COG), IQ-AI (IQAI), Trellus Health (TRLS), Renalytix (RENX), Totally (TLY), Chill Brands Group (CHLL), BiVictriX Therapeutics (BVX), Belluscura (BELL), and Argent BioPharma (MXC). These companies are all part of the "medical" sector.

Feedback vs.

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Feedback has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.42, indicating that its share price is 142% less volatile than the S&P 500.

52.8% of Feedback shares are owned by institutional investors. Comparatively, 42.4% of Induction Healthcare Group shares are owned by institutional investors. 11.0% of Feedback shares are owned by company insiders. Comparatively, 46.7% of Induction Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Feedback has higher earnings, but lower revenue than Induction Healthcare Group. Feedback is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£1.02M10.78-£3.49M-£0.26-317.31
Induction Healthcare Group£11.82M0.98-£14.18M-£0.15-83.33

In the previous week, Induction Healthcare Group had 6 more articles in the media than Feedback. MarketBeat recorded 6 mentions for Induction Healthcare Group and 0 mentions for Feedback. Induction Healthcare Group's average media sentiment score of 0.36 beat Feedback's score of 0.00 indicating that Induction Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Feedback Neutral
Induction Healthcare Group Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Feedback
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Induction Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Feedback has a net margin of 0.00% compared to Induction Healthcare Group's net margin of -120.26%. Feedback's return on equity of -32.67% beat Induction Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
FeedbackN/A -32.67% -21.47%
Induction Healthcare Group -120.26%-47.42%-10.25%

Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

Summary

Induction Healthcare Group beats Feedback on 8 of the 15 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£11.00M£179.73M£5.00B£1.57B
Dividend Yield4.56%6.58%2.87%6.85%
P/E Ratio-317.31553.62176.051,885.97
Price / Sales10.78674.892,437.28403,085.10
Price / Cash1.1239.9348.3735.09
Price / Book1.235.764.852.45
Net Income-£3.49M-£7.58M£103.66M£176.32M
7 Day Performance-15.38%2.54%3.90%0.84%
1 Month Performance-37.74%-4.47%-3.20%7.09%
1 Year Performance-37.74%-9.04%5.71%13.51%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INHC
Induction Healthcare Group
0 of 5 stars
GBX 11.55
-7.6%
N/A-39.9%£10.67M£11.82M-77.0083
COG
Cambridge Cognition
0 of 5 stars
GBX 49
-4.9%
N/A-47.8%£17.22M£12.77M-445.4580High Trading Volume
IQAI
IQ-AI
0 of 5 stars
GBX 1.55
+3.4%
N/A-33.3%£3.44M£538,190.00-13.676
TRLS
Trellus Health
0 of 5 stars
GBX 1.95
+2.5%
N/A-71.3%£3.15M£35,000.00-64.9031
RENX
Renalytix
0 of 5 stars
GBX 22
+2.3%
N/A-68.4%£26.38M£2.41M-61.11102
TLY
Totally
1.3075 of 5 stars
GBX 5.22
-0.6%
GBX 30
+474.7%
-75.9%£10.26M£121.20M-515.001,668
CHLL
Chill Brands Group
0 of 5 stars
GBX 2.26
+2.5%
N/A-65.4%£11.42M£624,187.00-225.607
BVX
BiVictriX Therapeutics
0 of 5 stars
GBX 12
+4.3%
N/A-18.0%£9.90MN/A-300.0017
BELL
Belluscura
0 of 5 stars
GBX 7.10
-2.1%
N/A-77.5%£11.67M£1.20M-118.3324Gap Down
MXC
Argent BioPharma
0 of 5 stars
GBX 22
+4.8%
N/AN/A£9.65M£1.32M-13.25N/ANews Coverage
Gap Up

Related Companies and Tools

This page (LON:FDBK) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners